271 related articles for article (PubMed ID: 20439122)
1. Exercise performance and quality of life is more impaired in Eisenmenger syndrome than in complex cyanotic congenital heart disease with pulmonary stenosis.
Müller J; Hess J; Hager A
Int J Cardiol; 2011 Jul; 150(2):177-81. PubMed ID: 20439122
[TBL] [Abstract][Full Text] [Related]
2. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome.
Tay EL; Peset A; Papaphylactou M; Inuzuka R; Alonso-Gonzalez R; Giannakoulas G; Tzifa A; Goletto S; Broberg C; Dimopoulos K; Gatzoulis MA
Int J Cardiol; 2011 Sep; 151(3):307-12. PubMed ID: 20580108
[TBL] [Abstract][Full Text] [Related]
3. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases.
Trojnarska O; Gwizdala A; Katarzynski S; Katarzynska A; Oko-Sarnowska Z; Grajek S; Kramer L
Int J Cardiol; 2010 Mar; 139(3):241-7. PubMed ID: 19042041
[TBL] [Abstract][Full Text] [Related]
4. Self-estimated physical functioning poorly predicts actual exercise capacity in adolescents and adults with congenital heart disease.
Gratz A; Hess J; Hager A
Eur Heart J; 2009 Feb; 30(4):497-504. PubMed ID: 19066211
[TBL] [Abstract][Full Text] [Related]
5. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival.
Dimopoulos K; Okonko DO; Diller GP; Broberg CS; Salukhe TV; Babu-Narayan SV; Li W; Uebing A; Bayne S; Wensel R; Piepoli MF; Poole-Wilson PA; Francis DP; Gatzoulis MA
Circulation; 2006 Jun; 113(24):2796-802. PubMed ID: 16769913
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
[TBL] [Abstract][Full Text] [Related]
7. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.
Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE
Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term.
Inuzuka R; Diller GP; Borgia F; Benson L; Tay EL; Alonso-Gonzalez R; Silva M; Charalambides M; Swan L; Dimopoulos K; Gatzoulis MA
Circulation; 2012 Jan; 125(2):250-9. PubMed ID: 22147905
[TBL] [Abstract][Full Text] [Related]
9. Improved exercise performance and quality of life after percutaneous pulmonary valve implantation.
Müller J; Engelhardt A; Fratz S; Eicken A; Ewert P; Hager A
Int J Cardiol; 2014 May; 173(3):388-92. PubMed ID: 24713459
[TBL] [Abstract][Full Text] [Related]
10. Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection.
Müller J; Christov F; Schreiber C; Hess J; Hager A
Eur Heart J; 2009 Dec; 30(23):2915-20. PubMed ID: 19692392
[TBL] [Abstract][Full Text] [Related]
11. Determinants of health-related quality of life in adults with congenital heart disease.
Bruto VC; Harrison DA; Fedak PW; Rockert W; Siu SC
Congenit Heart Dis; 2007; 2(5):301-13. PubMed ID: 18377445
[TBL] [Abstract][Full Text] [Related]
12. Shifts in exercise capacity are not reported adequately in patients with congenital heart disease.
Ehlert N; Hess J; Hager A
Congenit Heart Dis; 2012; 7(5):448-54. PubMed ID: 22489866
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.
Williams R; Houser L; Miner P; Aboulhosn J
Congenit Heart Dis; 2012; 7(1):12-5. PubMed ID: 22188797
[TBL] [Abstract][Full Text] [Related]
14. Minor symptoms of depression in patients with congenital heart disease have a larger impact on quality of life than limited exercise capacity.
Müller J; Hess J; Hager A
Int J Cardiol; 2012 Feb; 154(3):265-9. PubMed ID: 20926144
[TBL] [Abstract][Full Text] [Related]
15. Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease.
Gläser S; Opitz CF; Bauer U; Wensel R; Ewert R; Lange PE; Kleber FX
Chest; 2004 Feb; 125(2):368-76. PubMed ID: 14769711
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.
Tay EL; Papaphylactou M; Diller GP; Alonso-Gonzalez R; Inuzuka R; Giannakoulas G; Harries C; Wort SJ; Swan L; Dimopoulos K; Gatzoulis MA
Int J Cardiol; 2011 Jun; 149(3):372-6. PubMed ID: 20304507
[TBL] [Abstract][Full Text] [Related]
17. Comparison of health related quality of life with cardiopulmonary exercise testing in adolescents and adults with congenital heart disease.
Hager A; Hess J
Heart; 2005 Apr; 91(4):517-20. PubMed ID: 15772218
[TBL] [Abstract][Full Text] [Related]
18. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA
Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735
[TBL] [Abstract][Full Text] [Related]
19. Exercise capacity and the quality of life late after surgical correction of congenital heart defects.
Gierat-Haponiuk K; Haponiuk I; Chojnicki M; Jaworski R; Bakuła S
Kardiol Pol; 2011; 69(8):810-5. PubMed ID: 21850625
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study.
Mukhopadhyay S; Nathani S; Yusuf J; Shrimal D; Tyagi S
Congenit Heart Dis; 2011; 6(5):424-31. PubMed ID: 21914136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
